| International
Cancer Vaccine Symposium
Sunday, December 2, 2001
American Club, Tokyo, Japan
- Welcome
Ms. Vickie Paradise Green
Director, Tokyo American Club, Japan
- Opening Remarks
Dr. Lowell T. Harmison
Senior Executive Adviser, Hasumi International
Research Foundation, USA
- Chairman: Dr. Takehiko Sasazuki, Professor, Kyusyu
University, Japan
1st Presentation:
Dr. Dean L. Mann, Professor, University of Maryland,
Baltimore, School of Medicine, USA
“Dendritic Cell Acquisition of Candidate Tumor
Antigens, Maturation And T Cell Response”
2nd Presentation
Dr. Edgar G. Engleman, Professor, Stanford University,
USA
“Mobilization And Potential Clinical Uses of Dendritic
Cells”
3rd Presentation
Dr. James Mule, Professor, University of Michigan
Medical Center, USA
“Tumor Vaccine Strategies That Employ Dendritic
Cells AndTumor Lysates:
Experimental And Clinical Studies”
- Chairman: Dr. Kunihiko Tamaki, Professor, University
of Tokyo, Japan
4th Presentation
Dr. Georg Stingl, Professor, University of Vienna
Medical School, Austria
“Cutaneous Dendritic Cells ? Vehicles for the
Induction of Cancer Immunity”
5th Presentation
Dr. Jeffrey Weber, Professor, Keck/USC School
of Medicine in Los Angeles, USA
“Peptide-Based and Dendritic Cell Strategies for
Melanoma”
- Madam Chairman: Dr. Kayo Inaba, Professor, Kyoto
University, Japan
Panel Discussions
Dr. Edgar G. Engleman Dr. Kenichiro Hasumi
Dr. Lowell T. Harmison Dr. Kayo Inaba
Dr. Dean L. Mann Dr. James Mule
Dr. Takehiko Sasazuki Dr. Georg Stingl
Dr. Kunihiko Tamaki Dr. Jeffrey Weber
- Closing Remarks
＊Announcement on Scholarship
|
